Status:

COMPLETED

An Open Cohort of Childhood Tuberculosis in Mbarara National Referral Hospital, Uganda

Lead Sponsor:

Epicentre

Collaborating Sponsors:

Mbarara University of Science and Technology

Medecins Sans Frontieres, Netherlands

Conditions:

Tuberculosis

Eligibility:

All Genders

1-14 years

Brief Summary

The aims at investigating how the diagnosis of Tuberculosis in children in a setting of high TB and HIV prevalence can be improved and to assess the treatment outcomes and tolerance of the new WHO rec...

Detailed Description

Tuberculosis (TB) remains a leading cause of morbidity and mortality worldwide. The situation for children in this epidemic is complex because they are usually considered less infectious and therefore...

Eligibility Criteria

Inclusion

  • Any child with at least one of the following criteria:
  • Unexplained weight loss or documented failure to thrive or stagnant weight or Growth faltering on the growth charts over the past 3 months despite adequate nutrition and deworming,
  • Non - remittent cough or wheeze for more than 2 weeks,
  • Night sweats persistent or intermittent during the last 2 weeks
  • Prolonged fever (temperature \> 38°C) for 7 days, after common causes such malaria or pneumonia has been excluded.
  • Wheeze/Stridor - persistent, non remitting during the last 2 weeks
  • Chest pain - Persistent, localized, pleuritic in nature during the last 2 weeks
  • Unexplained fatigue, weakness, apathy, lethargy or reduced playfulness during the last 2 weeks
  • Painless superficial lymph node mass (\>2x2cm)-
  • Chronic onset meningitis (\>5days), lymphocytic predominance in CSF or meningitis not responding to antibiotic treatment (ref 8)
  • Recent gibbus
  • Abdominal distention with ascites OR
  • Any child with an abnormal chest X-ray (CXR) suggestive of TB (hilar/paratracheal adenopathy with/without airway compression, airspace opacification not responding to antibiotics or documented TB contact, lung cavities or miliary infiltrates) OR
  • Asymptomatic child with a history of recent contact (within past year) with a pulmonary TB smear or culture positive patient and an abnormal chest X-ray AND
  • Informed Consent signed by parent or legal representative

Exclusion

  • Current TB treatment (patient who received \< 3 days of treatment or patients receiving IPT could be still included) or TB treatment completed within the past 6 months.
  • Absence of informed consent
  • Living outside of Greater Mbarara region.
  • Unable or unwilling to attend to the follow-up visits

Key Trial Info

Start Date :

April 1 2012

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2014

Estimated Enrollment :

396 Patients enrolled

Trial Details

Trial ID

NCT01422798

Start Date

April 1 2012

End Date

December 1 2014

Last Update

March 2 2016

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.